News

Bajaj Finserv Mutual Fund launches Bajaj Finserv G

The objective of the Scheme is to generate credit risk-free returns through investments in sovereign securities issued by the Central Government and/o

Read More
Bajaj Finserv Mutual Fund launches Bajaj Finserv E

To generate long term capital appreciation from a diversified portfolio of predominantly equity and equity related securities while offering deduction

Read More
Motilal Oswal Mutual Fund launches Motilal Oswal A

The primary investment objective of the scheme is to generate long term growth of capital by predominantly investing in arbitrage opportunities presen

Read More
Mirae Asset Mutual Fund launches Mirae Asset Nifty

The investment objective of the scheme is to provide long-term capital appreciation from a portfolio investing in units of Mirae Asset Nifty India New

Read More
Mirae Asset Mutual Fund launches Mirae Asset Nifty

The investment objective of the scheme is to generate returns, before expenses, that are commensurate with the performance of the Nifty India New Age

Read More
ICICI Prudential Mutual Fund launches ICICI Pruden

The objective of the scheme is to invest in companies whose securities are included in Nifty 500 Index and subject to tracking errors, to endeavor to

Read More
Edelweiss Mutual Fund launches Edelweiss BSE Capit

The investment objective of the scheme is to generate returns that are in line with the performance of the BSE Capital Markets & Insurance Total Retur

Read More
Aditya Birla Sun Life Mutual Fund launches Aditya

The investment objective of the scheme is to generate returns corresponding to the total returns of the securities as represented by the CRISIL-IBX Fi

Read More
Baroda BNP Paribas Mutual Fund launches Baroda BNP

The primary investment objective of the scheme is to generate long term growth by investing predominantly in a portfolio of equity and equity related

Read More
Bajaj Finserv Mutual Fund launches Bajaj Finserv H

The objective of the scheme is to generate long term capital appreciation by predominantly investing in equity and equity related securities of pharma

Read More